NO982161L - Administrasjonsmedia for analgetiske, antiinflammatoriske og antipyretiske legemidler som inneholder dinitrogenoksid og farmas°ytiske sammensetninger som inneholder slike media og legemidler - Google Patents

Administrasjonsmedia for analgetiske, antiinflammatoriske og antipyretiske legemidler som inneholder dinitrogenoksid og farmas°ytiske sammensetninger som inneholder slike media og legemidler

Info

Publication number
NO982161L
NO982161L NO982161A NO982161A NO982161L NO 982161 L NO982161 L NO 982161L NO 982161 A NO982161 A NO 982161A NO 982161 A NO982161 A NO 982161A NO 982161 L NO982161 L NO 982161L
Authority
NO
Norway
Prior art keywords
drugs
media
analgesic
inflammatory
administration
Prior art date
Application number
NO982161A
Other languages
English (en)
Other versions
NO982161D0 (no
Inventor
Petrus Johannes Meyer
Original Assignee
Pitmy Int Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pitmy Int Nv filed Critical Pitmy Int Nv
Publication of NO982161D0 publication Critical patent/NO982161D0/no
Publication of NO982161L publication Critical patent/NO982161L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Administrasjonsmedium som omfatter løsninger av dinitrogenoksid i vann, alkoholer, etere eller oljer, og eventuelt innbefattende essensielle fett-syrer eller C-C-alkylestere derav forøker virknin-gen av analgetiske, antiinflammatoriske og antipyre-tiske legemidler. Legemidlene kan være kombinert med mediumet i en farmasøytisk sammensetning eller kan tas oralt ved å svelge legemidlet ved hjelp av mediumet .
NO982161A 1995-11-13 1998-05-12 Administrasjonsmedia for analgetiske, antiinflammatoriske og antipyretiske legemidler som inneholder dinitrogenoksid og farmas°ytiske sammensetninger som inneholder slike media og legemidler NO982161L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA959609 1995-11-13
PCT/IB1996/001366 WO1997017978A1 (en) 1995-11-13 1996-11-13 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs

Publications (2)

Publication Number Publication Date
NO982161D0 NO982161D0 (no) 1998-05-12
NO982161L true NO982161L (no) 1998-07-02

Family

ID=25585417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982161A NO982161L (no) 1995-11-13 1998-05-12 Administrasjonsmedia for analgetiske, antiinflammatoriske og antipyretiske legemidler som inneholder dinitrogenoksid og farmas°ytiske sammensetninger som inneholder slike media og legemidler

Country Status (13)

Country Link
US (1) US6221377B1 (no)
EP (1) EP0866713B1 (no)
JP (1) JP2000500449A (no)
CN (1) CN1102852C (no)
AT (1) ATE334689T1 (no)
AU (1) AU730495B2 (no)
BR (1) BR9611523A (no)
CA (1) CA2237306C (no)
DE (1) DE69636413T2 (no)
NO (1) NO982161L (no)
NZ (1) NZ322588A (no)
PT (1) PT866713E (no)
WO (1) WO1997017978A1 (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS49982B (sr) 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
EP0945134A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
DE19851604A1 (de) * 1998-11-09 2000-05-11 Messer Griesheim Gmbh Injektionsanästhesiemittel mit hydrophiler Phase
DE19851605A1 (de) * 1998-11-09 2000-05-11 Messer Griesheim Gmbh Mikropartikel enthaltendes Injektionsanästhesiemittel
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
AU2001283586A1 (en) * 2000-07-19 2002-01-30 Pitmy International N.V. Enhancement of the action of anti-infective agents
AU2001281416A1 (en) * 2000-07-19 2002-01-30 Pitmy International N.V. Transportation of nucleic acid substances
FR2812545B1 (fr) * 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
TWI290464B (en) * 2000-09-01 2007-12-01 Novartis Consumer Health Sa Treatment of burns
US20070112052A9 (en) * 2001-01-05 2007-05-17 Larry Caldwell Methods and compositions for treating headache pain with topical NSAID compositions
SE523017C2 (sv) * 2001-03-30 2004-03-23 Aga Ab Publ Spolfluidkomposition
US8329734B2 (en) * 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
CA2480826C (fr) 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US7714015B2 (en) * 2003-08-07 2010-05-11 Lil Brat Pharmaceuticals Of Marlette, Mi Method and composition for treating sunburned skin
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
CN101123982B (zh) * 2005-01-28 2015-06-17 西北大学 脂质和一氧化二氮组合作为用于增强疫苗功效的佐剂
US7442690B2 (en) * 2005-03-14 2008-10-28 P & L Enterprise Llc Topical treatment for psoriasis
US20060281775A1 (en) * 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain
EP1942902A1 (en) * 2005-09-30 2008-07-16 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
US9023400B2 (en) * 2006-05-24 2015-05-05 Flamel Technologies Prolonged-release multimicroparticulate oral pharmaceutical form
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
US20080031950A1 (en) * 2007-04-27 2008-02-07 Nectid Inc. Novel anelgesic combination
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination
US20080306132A1 (en) * 2007-06-07 2008-12-11 Praveen Hiremath Novel oral compositions of carporen
US20100297249A1 (en) 2007-07-05 2010-11-25 North-West University Enhancement of the efficacy of therapeutic proteins
CN102307464A (zh) * 2008-12-31 2012-01-04 尼特罗米加公司 含有硝基脂肪酸的营养制品
FR2944969B1 (fr) * 2009-04-29 2011-08-26 Air Liquide Utilisation de n2o gazeux dans le traitement des douleurs chroniques
US20110037455A1 (en) * 2009-08-17 2011-02-17 Oren Navot System for measuring electrical power
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
ES2677352T3 (es) * 2009-12-18 2018-08-01 Achelios Therapeutics, Inc. Métodos y composiciones para tratar y prevenir las cefaleas autonómicas trigeminales, la migraña y las afecciones vasculares
BR112012022073A2 (pt) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
ITMI20121316A1 (it) 2012-07-27 2014-01-28 Altergon Sa Complessi di condroitina ad assorbimento transcutaneo
CA3195252A1 (en) 2013-12-24 2015-07-02 Durect Corporation Uses of oxygenated cholesterol sulfates (ocs)
US20170266106A1 (en) 2014-12-01 2017-09-21 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
CN107530318A (zh) 2015-03-02 2018-01-02 阿福金制药有限责任公司 用大麻素的局部区域神经影响性疗法
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
WO2024162962A1 (en) * 2023-02-01 2024-08-08 Garrison Thomas E Mixtures including nitrous oxide
US11980717B1 (en) 2023-02-01 2024-05-14 Thomas E. Garrison Mixtures including nitrous oxide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0644766T3 (da) * 1992-06-08 1999-10-11 Pitmy Int Nv Dinitrogenoxid-holdigt dermatologisk præparat
GB9308306D0 (en) * 1993-04-22 1993-06-09 Univ Aberdeen Analgesic composition

Also Published As

Publication number Publication date
BR9611523A (pt) 1999-12-28
JP2000500449A (ja) 2000-01-18
US6221377B1 (en) 2001-04-24
CN1102852C (zh) 2003-03-12
CA2237306A1 (en) 1997-05-22
AU730495B2 (en) 2001-03-08
ATE334689T1 (de) 2006-08-15
WO1997017978A1 (en) 1997-05-22
NO982161D0 (no) 1998-05-12
PT866713E (pt) 2006-12-29
CN1205641A (zh) 1999-01-20
CA2237306C (en) 2008-10-07
EP0866713B1 (en) 2006-08-02
DE69636413D1 (de) 2006-09-14
NZ322588A (en) 1999-01-28
AU7637196A (en) 1997-06-05
DE69636413T2 (de) 2007-03-29
EP0866713A1 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
NO982161L (no) Administrasjonsmedia for analgetiske, antiinflammatoriske og antipyretiske legemidler som inneholder dinitrogenoksid og farmas°ytiske sammensetninger som inneholder slike media og legemidler
ES8403024A1 (es) Un procedimiento para la fabricacion de un preparado farmaceutico para uso externo, a base de un compuesto no esteroi- dico.
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
ES2161288T3 (es) Comprimido revestido con polimero que comprende amoxicilina y clavulanato.
PT1267832E (pt) Sistema auto-emulsionante de libertacao de farmaco
ATE59291T1 (de) 2-(2-fluor-4-biphenylyl)propionsaeure oder deren salze enthaltende arzneimittel.
ES2168271T3 (es) Composiciones farmaceuticas que contienen ciclosporinas.
DK1296670T3 (da) Terapeutiske fedtsyrekombinationer
DK0998916T3 (da) Lægemidler til administration til slimhinden
DE69415018D1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
DE69719189D1 (de) Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
DE60115402D1 (de) Neues selbstemulgierendes arzneistoffverabreichungssystem
TNSN97134A1 (fr) Comprime de maleate de trimebutine pellicule
DE69927374T2 (de) Entzündungshemmende pharmazeutische formulierungen
CO4700448A1 (es) Composiciones farmaceuticas
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
PT1249231E (pt) Formulacoes farmaceuticas contendo substancias activas anti-inflamatorias e sua utilizacao
CO5550418A2 (es) Formulaciones antihistaminicas para formas de dosificacion de capsula blanda
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
KR910014337A (ko) d-2-(6-메톡시-2-나프릴)-프로피온산의 광학활성 유도체와 이것을 함유한 약제학적 조성물
AR030647A1 (es) Composicion farmaceutica con actividad de agua especifica
AU570937B2 (en) Synergistic composition of hydroxyzine and salts thereof with nsaids
WO2023219592A3 (en) A tablet composition comprising paracetamol, chlorpheniramine and ascorbic acid
CO4340620A1 (es) Formulaciones farmaceuticas administrables de forma oral
JPS5423131A (en) Pharmaceutical composition containing acetylsalicylic acid and ethenzamide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application